Literature DB >> 11943280

Antifungal drug resistance of pathogenic fungi.

Dimitrios P Kontoyiannis1, Russell E Lewis.   

Abstract

Pathogenic fungi have many complex mechanisms of resistance to antifungal drugs. Information about the clinical, cellular, and molecular factors contributing to antifungal-drug resistance continues to accumulate. We critically review the diagnosis, epidemiology, and mechanisms of antifungal drug resistance of pathogenic fungi. Better understanding of this resistance should assist in developing better detection strategies for preventing and treating refractory mycoses in the future.

Mesh：

Substances：

Year:  2002        PMID： 11943280     DOI： 10.1016/S0140-6736(02)08162-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  103 in total

1.  The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia.

Authors:  Jingwen Tan; Jinqing Zhang; Wei Chen; Yi Sun; Zhe Wan; Ruoyu Li; Wei Liu
Journal:  Mycopathologia       Date:  2014-11-15       Impact factor: 2.574

Review 2.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

3.  Transcriptomic and proteomic profile of Aspergillus fumigatus on exposure to artemisinin.

Authors:  Poonam Gautam; Santosh Kumar Upadhyay; Wazid Hassan; Taruna Madan; Ravi Sirdeshmukh; Curam Sreenivasacharlu Sundaram; Wasudev Namdeo Gade; Seemi Farhat Basir; Yogendra Singh; Puranam Usha Sarma
Journal:  Mycopathologia       Date:  2011-07-14       Impact factor: 2.574

4.  Aspergillus fumigatus C-5 sterol desaturases Erg3A and Erg3B: role in sterol biosynthesis and antifungal drug susceptibility.

Authors:  Laura Alcazar-Fuoli; Emilia Mellado; Guillermo Garcia-Effron; Maria J Buitrago; Jordi F Lopez; Joan O Grimalt; J Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity.

Authors:  Daniel S Palacios; Thomas M Anderson; Martin D Burke
Journal:  J Am Chem Soc       Date:  2007-10-23       Impact factor: 15.419

Review 6.  Multidrug resistance in fungi.

Authors:  Kailash Gulshan; W Scott Moye-Rowley
Journal:  Eukaryot Cell       Date:  2007-09-14

7.  Risk factors for fluconazole-resistant Candida glabrata bloodstream infections.

Authors:  Ingi Lee; Neil O Fishman; Theoklis E Zaoutis; Knashawn H Morales; Mark G Weiner; Marie Synnestvedt; Irving Nachamkin; Ebbing Lautenbach
Journal:  Arch Intern Med       Date:  2009-02-23

8.  Metabolism and resistance of Fusarium spp. to the manzamine alkaloids via a putative retro pictet-spengler reaction and utility of the rational design of antimalarial and antifungal agents.

Authors:  Noer Kasanah; Lorelei Lucas Farr; Abbas Gholipour; David E Wedge; Mark T Hamann
Journal:  Mar Biotechnol (NY)       Date:  2014-02-20       Impact factor: 3.619

9.  Photodynamic inactivation of Candida albicans mediated by a low density of light energy.

Authors:  Gabriel Salles Barbério; Soraia Veloso da Costa; Mariana dos Santos Silva; Thaís Marchini de Oliveira; Thiago Cruvinel Silva; Maria Aparecida de Andrade Moreira Machado
Journal:  Lasers Med Sci       Date:  2013-03-14       Impact factor: 3.161

10.  Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection.

Authors:  Y Jin; H K Yip; Y H Samaranayake; J Y Yau; L P Samaranayake
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.